EWG Elevate’s Thermo Fisher Scientific TMO Stock Holding History

EWG Elevate’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10	Closed	-$5.51K	–	717
2022 Q4	$5.51K	Buy	+10	New	+$5.3K	﹤0.01%	458

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EWG Elevate's TMO Position: Q1 2023 in Review

EWG Elevate sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 10 shares — an estimated $5.51K sold.

EWG Elevate first reported a position in TMO in Q4 2022 and held it in 1 quarter. The position peaked at $5.51K in Q4 2022. 2,386 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

EWG Elevate reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 10 Thermo Fisher Scientific shares in Q1 2023, an estimated $5.51K.
EWG Elevate first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 1 quarter.
EWG Elevate's Thermo Fisher Scientific position peaked at $5.51K in Q4 2022.
2,386 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.